News
10-31-2022, 08:37 PM
A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations.
More... (https://www.news-medical.net/news/20221031/Study-expands-breast-cancer-patient-population-that-can-benefit-from-PARP-inhibitors.aspx)
More... (https://www.news-medical.net/news/20221031/Study-expands-breast-cancer-patient-population-that-can-benefit-from-PARP-inhibitors.aspx)